Person: Natalie Dakers

Terry Reidel

Terry Reidel has been appointed chairman of COM DEV International Inc. Reidel succeeds Keith Ainsworth, who remains a director with the Cambridge ON-based designer and manufacturer of space hardware systems He is the president of Terry Reidel Consulting, a founding member of Waterloo’s Manufacturing Innovation Network and former president and CEO of Kuntz Electroplating. Prior…

Natalie Dakers

Natalie Dakers is the recipient of this year’s BIOTECanada Industry Leadership Gold Leaf award. Dakers is CEO of the Centre for Drug Research and Development and has held a series of influential corporate and academic positions over a long career in the British Columbia life sciences sector. Past positions include president and CEO of Neuromed…

Dr Mario Thomas

Dr Mario Thomas has been appointed network manager of the Centre for Commercialization of Research, a national Centres of Excellence for Commercialization and Research (CECR) managed by the Ontario Centres of Excellence. Thomas has had a long and varied career in R&D and financing, beginning with Johnson & Johnson Inc . He also held senior…

Mark Whitmore

Mark Whitmore has been appointed chair of CANARIE Inc, Canada’s advanced network agency, replacing David Steeves. Whitmore is dean of science at the Univ of Manitoba. Also joining the 12-member CANARIE board of directors are: Jim Roche (vice-chair), former president and CEO of CMC Microsystems and former president, Tundra Semiconductors Inc; Louis Savoie (secretary treasurer),…

Dr Alan George

Dr Alan George has been appointed to the board of the Optical Regional Advanced Network of Ontario (ORANO), the owner of ORION, Ontario’s high speed research and education network. George is associate provost, information systems and technology and interim dean of graduate studies at the Univ of Waterloo. He is a pioneer in the application…

Natalie Dakers

Natalie Dakers has been appointed to the board of the Canada Foundation for Innovation. Dakers is co-founder, president and CEO of the Centre for Drug Discovery and Development in Vancouver. She is also an adjunct professor at the Univ of British Columbia in the faculty of pharmaceutical sciences and a leading member of Canada’s life…

Dr Christopher Gallen

Dr Christopher Gallen has been appointed president and CEO of Vancouver-based Neuromed Technologies Inc, a private biopharmaceutical firm focused on drugs for chronic pain. He replaces founding president

Natalie Dakers

Natalie Dakers (see below), who helped the firm move through Phase I clinical trials and raise $70 million in venture capital financing. Gallen was most recently with Wyeth Research where he held the posi